Vertex Pharmaceuticals
VRTX
#151
Rank
C$192.21 B
Marketcap
C$758.13
Share price
1.65%
Change (1 day)
28.23%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): C$21.91

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$22.45. In 2025 the company made an earnings per share (EPS) of C$22.16 an increase over its 2024 EPS that were of C-$2.95.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$21.91-1.15%
2025C$22.16-850.97%
2024C-$2.95-114.67%
2023C$20.118.17%
2022C$18.5942.64%
2021C$13.03-12.67%
2020C$14.93128.01%
2019C$6.55-44.54%
2018C$11.80670.09%
2017C$1.53-327.66%
2016C-$0.67-79.65%
2015C-$3.31-26.43%
2014C-$4.5053.92%
2013C-$2.92316.33%
2012C-$0.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-57.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$8.38-62.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C-$4.44-119.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.42-93.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47-71.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
C-$3.45-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA